ARS Pharmaceuticals Inc. (SPRY)
ARS Pharmaceuticals Max Pain By Strike
SPRY trades at $13.79, 8.1% below the near-term max pain of $15 expiring Sep 19, 2025 (31 days). Look for upward drift as max pain acts as a magnet pulling price higher. Max pain is falling across expirations ($2.5-$17.5), signaling increased put positioning or downside protection. Key magnetic zone at 15 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
ARS Pharmaceuticals Max Pain By Expiry
Max pain for SPRY shows a downward trend from 17.5 to 2.5, indicating bearish sentiment or hedging activity. The 127% spread signals divergent expectations across timeframes. Levels distributed around 13.79. Strong magnetic level at 15 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 15 | 1.21 (8.77%) |
| Oct 17, 2025 | 2.5 | -11.29 (-81.87%) |
| Dec 19, 2025 | 15 | 1.21 (8.77%) |
| Jan 16, 2026 | 17.5 | 3.71 (26.90%) |
| Feb 20, 2026 | 5 | -8.79 (-63.74%) |
| Mar 20, 2026 | 15 | 1.21 (8.77%) |
| Apr 17, 2026 | 12.5 | -1.29 (-9.35%) |